News

Hosted on MSN15d
Biogen’s Friedreich’s ataxia treatment authorised in UK
Biogen Netherlands has received marketing authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its Skyclarys (omaveloxolone) to treat Friedreich's ataxia in ...
Pharmabiz15d
UK MHRA grants marketing authorisation to Biogen’s omaveloxolone to treat Friedreich’s ataxia
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved omaveloxolone (Skyclarys), the first treatment for patients aged 16 and over, in the UK for a rare neurodegenerative ...